ArticleFrontiers in oncology2020
The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy.
Open access · goldAbstract read
In one paragraph
Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers.
0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed
20.4field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
89 citing papers in PubMed, 142 citations in OpenAlex.
- Daily adaptive 1.5 T MR-Linac image-guided re-irradiation for prostate cancer: an international retrospective experience.Clinical and translational radiation oncology · 2027Article
- Feasibility of dose accumulation for assessing treatment-related side effects in MR-guided abdominal SABR: A single-institution study.Clinical and translational radiation oncology · 2026Article
- Deep learning-enhanced image registration for accelerating daily adaptive magnetic resonance imaging-guided prostate radiotherapy.Physics and imaging in radiation oncology · 2026Article
- Article
- Conditional organs-of-interest segmentation with plausible inter-fraction variation simulation for pancreatic magnetic resonance-guided radiotherapy in limited-data settings.Physics and imaging in radiation oncology · 2026Article
- Leveraging large language models to populate structured clinical case report forms from unstructured medical notes in radiation oncology.Clinical and translational radiation oncology · 2026Article
- Feasibility and Tumor Dynamics of Daily MRI-Guided Online Adaptive Radiotherapy for Brain Glioma.CNS neuroscience & therapeutics · 2026Observational
- Technical Development and Implementation of 3D-QALAS on a 1.5T MR-Linac for the Brain: A Prospective R-IDEAL Stage 0/1 Technology Development Report.medRxiv : the preprint server for health sciences · 2026Article
- Dosimetric comparison between brachytherapy and MR-Linac as a boost modality for locally advanced cervical cancer.Clinical and translational radiation oncology · 2026Article
- Optimising acute toxicity monitoring in prostate MR-guided radiotherapy workflow: Results from a prospective study using multiple electronic PRO assessments.Technical innovations & patient support in radiation oncology · 2026Article
- Feasibility of reusing online-generated treatment plans for adaptive radiotherapy in prostate cancer.Physics and imaging in radiation oncology · 2026Article
- Balancing dose preservation and treatment efficiency in motion-managed magnetic resonance image-guided radiotherapy of pancreatic cancer.Physics and imaging in radiation oncology · 2026Article
- Article
- Impact evaluation of intra-fractional variation on online adaptive radiotherapy for postoperative cervical and endometrial cancer.World journal of clinical oncology · 2025Article
- Comparison of deep learning-based segmentation and registration using pre-treatment contours for online rectal delineation in magnetic resonance-guided radiotherapy.Physics and imaging in radiation oncology · 2025Article
- Apparent diffusion coefficient increases during short course radiotherapy in rectal tumours: Results from a multicentre longitudinal trial.Physics and imaging in radiation oncology · 2025Article
- Towards clinical implementation of T2-weighted cine imaging for intrafraction drift correction workflows on the 1.5 Tesla magnetic resonance-linear accelerator.Physics and imaging in radiation oncology · 2025Article
- Feasibility of a reduced gadolinium dose protocol for MRI-guided radiotherapy in glioblastoma.Acta oncologica (Stockholm, Sweden) · 2025Article
- From standardized to individualized margins for online adaptive tumor dose escalation in rectal cancer.Radiation oncology (London, England) · 2025Article
- Prostate motion in magnetic resonance imaging-guided radiotherapy and its impact on margins.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2025Article
29 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
34 authors at 11 institutions in 5 countries.
Sophie R de Mol van OtterlooDepartment of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands.
John P ChristodouleasElekta AB, Stockholm, Sweden.
Erwin L A BlezerDivision of Imaging, University Medical Center Utrecht, Utrecht, Netherlands.
Hafid AkhiatElekta AB, Stockholm, Sweden.
Kevin BrownElekta AB, Stockholm, Sweden.
Ananya ChoudhuryThe Christie National Health Service Foundation Trust, Manchester, United Kingdom.
Dave EggertElekta AB, Stockholm, Sweden.
Beth A EricksonDepartment of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, United States.
Corinne Faivre-FinnThe Christie National Health Service Foundation Trust, Manchester, United Kingdom.
Clifton D FullerDepartment of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Joel GoldweinElekta AB, Stockholm, Sweden.
Shaista HafeezThe Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, London, United Kingdom.
Emma HallClinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom.
Kevin J HarringtonThe Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, London, United Kingdom.
Uulke A van der HeideDepartment of Radiation Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands.
Robert A HuddartThe Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, London, United Kingdom.
Martijn P W IntvenDepartment of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands.
Anna M KirbyThe Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, London, United Kingdom.
Susan LalondrelleThe Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, London, United Kingdom.
Claire McCannDepartment of Radiation Oncology, Sunnybrook Health Sciences Center/Odette Cancer Center, Toronto, ON, Canada.
Bruce D MinskyDepartment of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Stella MookDepartment of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands.
Marlies E NoweeDepartment of Radiation Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands.
Uwe OelfkeThe Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, London, United Kingdom.
Kristina OrrlingLygature, Utrecht, Netherlands.
Arjun SahgalDepartment of Radiation Oncology, Sunnybrook Health Sciences Center/Odette Cancer Center, Toronto, ON, Canada.
Jeffrey G SarmientoDepartment of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Christopher J SchultzDepartment of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, United States.
Robbert J H A TersteegDepartment of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands.
Rob H N TijssenDepartment of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands.
Alison C TreeThe Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, London, United Kingdom.
Baukelien van TriestDepartment of Radiation Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands.
William A HallDepartment of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, United States.
Helena M VerkooijenDivision of Imaging, University Medical Center Utrecht, Utrecht, Netherlands.
University Medical Center Utrecht · NLElekta (Sweden) · SEInstitute of Cancer Research · GBRoyal Marsden NHS Foundation Trust · GBMedical College of Wisconsin · USThe Netherlands Cancer Institute · NLThe University of Texas MD Anderson Cancer Center · USSunnybrook Health Science Centre · CALygature · NLNational Health Service · GBThe Christie NHS Foundation Trust · GB
Funding
imaging Radiation-Associated Dysphagia (iRAD)R01CA218148 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI FULLER, CLIFTON DAVID, HUTCHESON, KATHERINE ARNOLD · 2017 to 2019
$810kCancer Research UK 15955Cancer Research UK 19727Cancer Research UK 21993Cancer Research UK 28284Medical Research Council MC_EX_MR/M009068/1Medical Research Council MR/M009068/1NCI NIH HHS R01 CA218148
Abstract
PubMed holds no abstract for this paper.
Indexed as
adaptive radiotherapyfunctional imagingimage-guidancemagnetic resonance imagingMR-guided radiation therapy (MRgRT)MRIMR-linacradiotherapy
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.